TY -的A2 Boyanov Mihail a . AU - Aldahash雷德PY - 2021 DA - 2021/12/02 TI -罕见的演示间变性大细胞淋巴瘤患者低血糖的SP - 6843103六世- 2021 AB -间变性大细胞淋巴瘤是一种罕见的侵袭性非霍奇金淋巴瘤,和到达最终诊断肿瘤医疗服务提供者是一个挑战。通常,它涉及到淋巴结外侵犯淋巴结和肺等组织,皮肤,和其他软组织。表示通过扩展到不同的器官,如肝脏、肺、骨头、脾、甲状腺是罕见的。因此,其他器官的参与是非常罕见的,因为我们发现在一名54岁男性病人,一个已知的高血压和终末期肾病血液透析,急诊治疗的历史的广义的弱点和减肥大约20公斤两个月。肿瘤细胞CD45阳性、CD30 CD15, MUMi,和ki - 67(80%)和负CD20, PAX-5, CD79a, CD3, CD5, CD10, BCL6, BCL2, EMA, ALK-1, CD138。病人血糖过低的hypercalcemic和相应的管理。病人评估,第三个评估显示,低血糖是解决由于地塞米松。病人的血糖储存耗尽最有可能是由于肝脏介入加可怜的一般情况。它是断言,病人的低血糖可能与他潜在的恶性肿瘤。此外,病人建议开始平板二氮嗪45毫克每天三次(3毫克/公斤/天TID)除了左旋甲状腺素片50微克每天一次。 Tablet diazoxide was stopped, and nutritional support was recommended. This case reveals a rare systematic ALK-1-negative anaplastic large-cell lymphoma that involves multiple organs. The main learning point from this report is that these tumors can present atypically even in adults and can be ALK-1 negative, which is contrary to the typical systematic anaplastic large-cell lymphomas that are positive for ALK. SN - 2090-6501 UR - https://doi.org/10.1155/2021/6843103 DO - 10.1155/2021/6843103 JF - Case Reports in Endocrinology PB - Hindawi KW - ER -